Use the title search or filter by topic and publication date to quickly find relevant clinical guidance.

August 2021

Analgesic options for surgical abortion (also called procedural abortion) beyond local anesthesia and minimal sedation include moderate sedation, deep sedation and general anesthesia. These clinical recommendations review the effectiveness of various moderate sedation, deep sedation, and general anesthesia regimens for pain control during abortion; medication regimens used to induce analgesia and anesthesia; patient factors affecting ... Read more >

March 2021

Individuals who have bleeding disorders, thrombophilias, a history of venous thromboembolism (VTE), or who are taking anticoagulation medication for other reasons may present for abortion. Clinicians should be aware of risk factors and histories concerning for excessive bleeding and thrombotic disorders around the time of abortion. This document will focus on how to approach abortion ... Read more >

December 2020

Women should be provided with evidence-based information when considering options for contraception and pregnancy management. When counseling about health conditions and available treatments, healthcare practitioners should employ strategies that encourage the incorporation of informed patient preferences into a shared decision-making process with the patient. To optimize the health of women at risk of experiencing adverse ... Read more >

August 2020

Medication abortion, also referred to as medical abortion, is a safe and effective method of providing abortion. Medication abortion involves the use of medicines rather than uterine aspiration to induce an abortion. The U.S. Food and Drug Administration (FDA)-approved medication abortion regimen includes mifepristone and misoprostol. The purpose of this document is to provide updated ... Read more >

April 2020

Women at high risk for maternal morbidity and mortality have unique needs for reproductive health services, including prenatal and postpartum care, contraception, and abortion. However, barriers such as restrictive state legislation, poor access to trained providers, limits in insurance coverage, and clinical challenges in assessing and communicating risk often make it difficult for these women ... Read more >

1 4 5 6 7 8 10